Skip to main content
Epigral Limited logo

Epigral Limited — Investor Relations & Filings

Ticker · EPIGRAL ISIN · INE071N01016 LEI · 3358008YTT28JYLL4516 BSE.NS Manufacturing
Filings indexed 551 across all filing types
Latest filing 2023-09-12 Regulatory Filings
Country IN India
Listing BSE.NS EPIGRAL

About Epigral Limited

https://epigral.com/

Epigral Limited, formerly Meghmani Finechem Limited, operates an integrated chemical complex specializing in chlor-alkali and derivative products. The company’s core portfolio includes caustic soda, chlorine, and hydrogen, which serve as building blocks for its value-added downstream products. Key offerings include chloromethanes, hydrogen peroxide, and CPVC resin. Epigral is the first domestic producer of Epichlorohydrin (ECH), utilizing a bio-based manufacturing process. Its products are essential inputs for various applications in pharmaceuticals, textiles, water treatment, and plastics. The company focuses on expanding its specialty chemical portfolio through backward and forward integration, utilizing advanced technology to optimize production efficiency and meet the requirements of diverse global markets.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges about scheduled one-on-one meetings with investors and analysts. It references Regulation 30 and SEBI Listing Obligations, indicating it is a regulatory disclosure. It mentions that the latest earnings and corporate presentations are already available on the company's website, but does not contain any financial data or detailed presentation itself. The document length is only 1934 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this is an announcement of meetings and investor interactions, fitting best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-09-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about scheduled one-on-one virtual meetings with financial analysts or fund managers. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to disclosure of material events. The document mentions that the latest earnings and corporate presentations are already available on the company's website, but does not contain any financial data or detailed report itself. The length is only 2001 characters, indicating it is a brief announcement rather than a full report. Therefore, this document is an announcement of an event (investor meetings) and not a financial report or presentation. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2023-09-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (2001 characters) addressed to stock exchanges informing about scheduled one-on-one virtual meetings with analysts/fund managers. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document mentions that the latest earnings and corporate presentations are already available on the company's website, indicating this is an announcement of meetings rather than the presentations themselves. There is no financial data or detailed report content included. The document serves as an update or intimation about investor meetings, which fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than a formal investor presentation or earnings release. The document is too short and does not contain actual financial results or detailed presentation content, so it is not classified as ER or IP. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-09-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about a scheduled one-on-one video conference meeting with WhiteOak Capital Management. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to disclosure of material events. The document mentions that the latest earnings and corporate presentations are already available on the company's website, indicating this is an announcement of an investor meeting rather than the presentation or report itself. The document length is short (1703 characters), and it does not contain any financial data or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about an investor meeting and not the actual investor presentation or earnings release.
2023-09-06 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the change of the company's name from 'Meghmani Finechem Limited' to 'Epigral Limited'. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements, Regulation 30, which pertains to material events or information. The document includes a media release announcing the name change and the effective date of the new name and symbol on the exchanges. There is no financial data, no detailed report, no earnings information, or management discussion. The document is an official announcement of a corporate action (name change) and not a financial report or detailed filing. This fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-09-06 English
Name and Symbol Change
Regulatory Filings Classification · 95% confidence The document is a short circular from the National Stock Exchange of India informing about a change in the company name and stock symbol effective from a specific date. It does not contain financial data, management discussion, voting results, or any report content. It is an official announcement related to a capital market change (name and symbol change). Given the nature and length of the document, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-09-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.